E. Bargagli (Siena, Italy), A. Prasse (Hannover, Germany)
Identification of indoor fungal antigens in assessment of hypersensitivity pneumonitis – an alternate approach
F. Hernandez Gonzalez (Barcelona, Spain), M. Calvo (Barcelona, Spain), L. Arosemena Angulo (Barcelona, Spain), M. Sanchez (Barcelona, Spain), M. Benegas (Barcelona, Spain), J. Ramirez (Barcelona, Spain), C. Lucena (Barcelona, Spain), C. Agusti (Barcelona, Spain), M. Boada (Barcelona, Spain), R. Castellanos (Barcelona, Spain), S. Rodriguez-Garcia (Barcelona, Spain), I. Bobolea (Barcelona, Spain), E. Arismendi (Barcelona, Spain), M. Pascal (Barcelona, Spain), O. Viñas (Barcelona, Spain), E. Ruiz (Barcelona, Spain), S. Prieto Gonzalez (Barcelona, Spain), G. Espinosa (Barcelona, Spain), S. Cuerpo (Barcelona, Spain), J. Francesqui (Barcelona, Spain), J. Sellares (Barcelona, Spain)
|    |
Cellular consequences of uncharacterized surfactant protein-A2 (SFTPA2)-gene mutations associated with familial IPF and lung cancer
K. Guenther (Giessen, Germany), W. Seeger (Giessen, Germany), A. Guenther (Giessen, Germany), M. Korfei (Giessen, Germany)
| |
Nintedanib mediates effective modulation of relevant pro-fibrotic biomarkers ex vivo
C. Hesse (Hannover, Germany), S. Wollin (Biberach an der Riss, Germany), S. Konzok (Hannover, Germany), M. Niehof (Hannover, Germany), D. Leeming (Herlev, Denmark), S. Rønnow (Herlev, Denmark), J. Sand (Herlev, Denmark), P. Braubach (Hannover, Germany), D. Jonigk (Hannover, Germany), M. Kühnel (Hannover, Germany), G. Warnecke (Hannover, Germany), H. Fieguth (Hannover, Germany), O. Pfennig (Hannover, Germany), K. Sewald (Hannover, Germany), A. Braun (Hannover, Germany)
| |
Identification of an IL-6-dependent macrophage population required for driving fibrotic disease
E. Doran (South San Francisco, United States of America), D. Ruane (South San Francisco, United States of America), A. Abbas (South San Francisco, United States of America), D. Depianto (South San Francisco, United States of America), P. Caplazi (South San Francisco, United States of America), C. Emson (South San Francisco, United States of America), J. Arron (South San Francisco, United States of America)
| |
Squeaks in hypersensitivity pneumonitis: prevalence and clinical correlates
E. Diamanti (Lausanne, Switzerland), C. Daccord (Lausanne, Switzerland), S. Ahmetovic (Lausanne, Switzerland), N. Bacco (Lausanne, Switzerland), R. Lazor (Lausanne, Switzerland)
| |
Should we biopsy one or two lobes? – diagnostic yield and risks of transbronchial lung cryobiopsy
N. Teixeira China Pereira (Vila Nova de Gaia, Portugal), D. Machado (Vila Nova de Gaia, Portugal), I. Sucena (Vila Nova de Gaia, Portugal), D. Coutinho (Vila Nova de Gaia, Portugal), C. Nogueira (Vila Nova de Gaia, Portugal), I. Marques (Vila Nova de Gaia, Portugal), A. Sanches (Vila Nova de Gaia, Portugal), A. Oliveira (Vila Nova de Gaia, Portugal), J. Almeida (Vila Nova de Gaia, Portugal), S. Campainha (Vila Nova de Gaia, Portugal), S. Neves (Vila Nova de Gaia, Portugal)
| |
Pneumotox metrics: Drugs, patterns, users and countries. Foreground and quiet zones
P. Camus (Dijon, France), C. Camus (Dijon, France), G. Beltramo (Dijon, France), P. Bonniaud (Dijon, France)
| |